|
TTD
Drug ID:
DAP000955
Drug
Information |
Name | Quinethazone | Synonyms | ZINC00000686; Quinethazon; Quinetazona [INN-Spanish]; BPBio1_001078; Quinethazone [INN:BAN:JAN]; Quinethazone (JAN/INN); 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-ethyl-4-oxo-; CID6307; Chinetazone [DCIT]; Chinethazone; Hydromox (TN); SMR001233433; AB00514022; Quinetazona; MLS002154126; DB01325; 6-Quinazolinesulfonamide, 7-chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-; Quinethazonum [INN-Latin]; CCRIS 6098; BSPBio_000980; HSDB 3392; BRN 0818554; Quinethazone (aquamox); Chinetazone; Prestwick3_001050; 5-25-09-00214 (Beilstein Handbook Reference); 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide; Chinethazonum; Idrokin; AC1L1M8L; 7-Chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone; Prestwick0_001050; MolPort-002-070-273; CHEMBL1532; Quinethazonum; UNII-455E0S048W; LS-1624; 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide; Prestwick1_001050; 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide; BRD-A59303141-001-03-9; HMS1571A22; 73-49-4; QUINETHAZONE; Hydromox; D00461; 2-Ethyl-7-chloro-1,2,3,4-tetrahydro-4-oxochinazolin-6-sulfonamid; CL 36010; Aquamox; Prestwick2_001050; C10H12ClN3O3S; 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-sulfamoylquinazoline; EINECS 200-801-7; C07342; SPBio_002910 | Trade Name | Hydromox | Indication | Hypertension | Approved [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | Therapeutic Class | Antihypertensive Agents | CAS Number | CAS 73-49-4 | Formular | C10H12ClN3O3S | PubChem Compound ID | CID 6307. | PubChem Substance ID | SID 9549. | SuperDrug ATC ID | C03BA02; | SuperDrug CAS ID | 000073494; | Target | Carbonic anhydrase |  | Inhibitor | [2] | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 013264 To Reference | Ref 2 | Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2567-73. Epub 2008 Mar 20. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|